BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1178961)

  • 21. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.
    Katz AI; Hampers CL; Merrill JP
    Medicine (Baltimore); 1969 Sep; 48(5):333-74. PubMed ID: 4909606
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of the treatment of patients with chronic kidney failure on nephrogenic osteodystrophy].
    Tret'iakov AE
    Klin Med (Mosk); 1984 Jun; 62(6):40-4. PubMed ID: 6381878
    [No Abstract]   [Full Text] [Related]  

  • 23. [The reaction of plasma enzymes during extracorporeal and peritoneal dialysis].
    Kokot F; Kuska J; Koziak H; Kowalik M
    Z Gesamte Inn Med; 1969 Oct; 24(20):702-5. PubMed ID: 5370934
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of some enzymes in the serum and urine in chronic renal failure].
    Skiba W; Skurzewski J
    Pol Tyg Lek; 1974 Jun; 29(23):977-80. PubMed ID: 4152013
    [No Abstract]   [Full Text] [Related]  

  • 25. [The relationship between bone mineral density and secondary hyperparathyroidism bone disease].
    Ning JP; Sun M; Toru I; Etsuo Y
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):77-9. PubMed ID: 12212259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The behavior of serum "liver enzyme" activity in children with chronic renal failure, hemodialysis and kidney transplantation].
    Otting U; Hellmann C; Gellert S; Devaux S; Grossmann P
    Z Urol Nephrol; 1989 Jun; 82(6):331-8. PubMed ID: 2569799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Parathyroid hormone values in patients on chronic dialysis treatment].
    Mushmov D; Milkov V; Kiriakov Z; Zakharieva B
    Vutr Boles; 1986; 25(3):59-62. PubMed ID: 3765580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Serum-alkaline-phosphatase during maintenance haemodialysis.
    Stepán J; Pilarova T
    Lancet; 1975 May; 1(7917):1188-9. PubMed ID: 48800
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The characteristics with regard to the serum alkaline phosphatase in patients under longterm hemodialysis (author's transl)].
    Matsuda Y; Kijima Y; Sasaoka T; Kanayama M
    Rinsho Byori; 1978 May; 26(5):451-6. PubMed ID: 671797
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis.
    De Broe ME; Bosteels V; Wieme RJ
    Lancet; 1974 Apr; 1(7860):753-4. PubMed ID: 4132494
    [No Abstract]   [Full Text] [Related]  

  • 34. [Two cases of chronic renal failure on maintenance hemodialysis, presenting macro creatine kinase].
    Nakashima A; Toyama T; Okuda K; Kuroda H
    Nihon Jinzo Gakkai Shi; 1986 Jun; 28(6):829-35. PubMed ID: 3773315
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical-radiographic studies of the oral cavity in patients on maintenance hemodialysis].
    Papademetriou D; Memmos D; Liamos O; Papademetriou M; Hatzifotiadis D
    Stomatologia (Athenai); 1985; 42(1):63-72. PubMed ID: 3870235
    [No Abstract]   [Full Text] [Related]  

  • 36. Intestinal alkaline phosphatase in patients with chronic renal failure.
    Alpers DH; DeSchryver-Kecskemeti K; Goodwin CL; Tindira CA; Harter H; Slatopolsky E
    Gastroenterology; 1988 Jan; 94(1):62-7. PubMed ID: 3335299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood and urinary cadmium in chronic renal failure.
    Willden EG; Hyne BE
    Nephron; 1974; 13(3):253-7. PubMed ID: 4418784
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patients.
    Stammler G; Klooker P; Bommer J; Ziegler T; Fiehn W; Manthey J; Ritz E
    Blood Purif; 1985; 3(4):192-8. PubMed ID: 3914306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Accumulation of physiologically active macromolecules in patients under hemodialysis, with special reference to the significance of high ribonulcease activities].
    Kobayashi K; Takasugi N; Toyota K; Ono T; Irino S
    Nihon Jinzo Gakkai Shi; 1976 Apr; 18(4):269-79. PubMed ID: 1034828
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ionised calcium in the course of hemodialysis treatment].
    Kraska C; Binswanger U; Záruba K; Knob M; Tammilehto E
    Klin Wochenschr; 1972 Sep; 50(17):819-23. PubMed ID: 5076406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.